Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Heart Failure and Diabetes
NCT01690091Phase 3Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Nov 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in heart failure (HF), type 2 diabetes mellitus (T2DM), sponsored by Institute for Clinical and Experimental Medicine. Started Nov 2012; status: completed.
02
Drugs
metformin
03
Conditions
heart failure (HF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01690091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690091.